Skip to main content
MDGL
NASDAQ Life Sciences

Madrigal Posts $1.83 Third-Quarter EPS

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$431.155
Mkt Cap
$9.961B
52W Low
$399
52W High
$615
52W Position info
8.1% above low
Off High info
30% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

MDGL is trading near its 52-week low of $399 (8.1% above the low) on elevated volume (1.8× avg).

Summary

Madrigal reported third-quarter EPS of $1.83, its first quarterly print since Q2 Rezdiffra net sales of $364.3 million, up 71% year over year, with more than 49,000 patients on therapy. The headline carries only the EPS line, so revenue, guidance and the Rezdiffra trajectory are not yet in hand, though Rezdiffra sales year to date have exceeded $1.0 billion and third-quarter operating income came in at USD 55.989 million. For a company with a roughly $10 billion market value trading above $400 a share, the profit line is the number that matters most after a quarter that was still running a net loss. The Q2 net loss was $57.9 million, so a positive $1.83 EPS implies a sharp swing toward profitability.

At the time of this announcement, MDGL was trading at $431.16 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10B. The 52-week trading range was $399.00 to $615.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

MDGL - Latest Insights

MDGL
Nov 06, 2026, 5:30 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $399.93
Real-time Price: $421.99 info
Change: +$22.06 (+6%) info
Market Cap: $9.803B info
MDGL
Nov 05, 2026, 10:35 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $408.99
Real-time Price: $421.99 info
Change: +$13.00 (+3%) info
Market Cap: $9.803B info
MDGL
Nov 03, 2026, 9:10 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $428.01
Real-time Price: $421.99 info
Change: -$6.02 (-1%) info
Market Cap: $9.803B info
MDGL
Nov 03, 2026, 8:08 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $477.00
Real-time Price: $421.99 info
Change: -$55.01 (-12%) info
Market Cap: $9.803B info
MDGL
Aug 03, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $475.00
Real-time Price: $421.99 info
Change: -$53.01 (-11%) info
Market Cap: $9.803B info